Systemic corticosteroid therapy: patients' adherence to dietary advice and relationship between food intake and corticosteroid-induced lipodystrophy;Corticothérapie systémique et alimentation : suivi des recommandations diététiques et relation entre apports alimentaires et apparition d'une lipodystrophie

Revue de Medecine Interne

Volumn 28, Issue 5, 2007, Pages 284-288

  Fardet, L ^a,b   Flahault, A ^b   Kettaneh, A ^a   Tiev, K P ^a   Toledano C ^a   Lebbe, C ^c   Cabane, J ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HÔPITAL TENON   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Corticosteroids; Dietary advice; Lipodystrophy

Indexed keywords

CORTICOSTEROID; PREDNISONE;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DIET; FAT INTAKE; FEMALE; FOOD INTAKE; FRANCE; GIANT CELL ARTERITIS; HUMAN; LIPODYSTROPHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PROTEIN INTAKE; QUESTIONNAIRE; SODIUM INTAKE; SODIUM RESTRICTION;

ADRENAL CORTEX HORMONES; DIET; DIET RECORDS; FEMALE; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 34247219786     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.12.013     Document Type: Article

References (15)

1. Walsh L.J., Wong C.A., Pringle M., and Tattersfield A.E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313 7053 (1996) 344-346
2. Miggiano G.A., and Migneco M.G. Diet and chronic corticosteroid therapy. Clin. Ter. 155 5 (2004) 213-220
3. Williams L.C., and Nesbitt Jr. L.T. Update on systemic glucocorticosteroids in dermatology. Dermatol. Clin. 19 1 (2001) 63-77
4. Nesbitt Jr. L.T. Minimizing complications from systemic glucocorticosteroid use. Dermatol. Clin. 13 4 (1995) 925-939
5. Hercberg S., Preziosi P., Briancon S., Galan P., Triol I., Malvy D., et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SUVIMAX study-design, methods, and participant characteristics. Supplémentation en vitamines et minéraux antioxydants. Control. Clin. Trials 19 4 (1998) 336-351
6. Price S.R., Du J.D., Bailey J.L., and Mitch W.E. Molecular mechanisms regulating protein turnover in muscle. Am. J. Kidney Dis. 37 1 Suppl 2 (2001) S112-S114
7. Fardet L, Cabane J, Kettaneh A, Lebbé C, Morel P, Flahault A. Lipodystrophy due to long-term (> 3 months), high dosage (> 20 mg/d) corticosteroid therapy: one-year incidence and risk factors. Soumis pour publication à Journal of Rheumatology.
8. Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's feeling. Sous presse British Journal of Dermatology.
9. Ammassari A., Antinori A., Cozzi-Lepri A., Trotta M.P., Nasti G., Ridolfo A.L., et al., AdICoNA Study Group, LipoICoNA Study Group. Relationship between HAART adherence and adipose tissue alterations. J. Acquir. Immune Defic. Syndr. 31 Suppl 3 (2002) S140-S144
10. Fardet L, Cabane J, Kettaneh A, Lebbé C, Flahault A. Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Soumis pour publication à Rheumatology.
11. Whitworth J.A., Schyvens C.G., Zhang Y., Mangos G.J., and Kelly J.J. Glucocorticoid-induced hypertension: from mouse to man. Clin. Exp. Pharmacol. Physiol. 28 12 (2001) 993-996
12. + retention in man is not mediated by the mineralocorticoid receptor. J. Endocrinol. Invest. 18 7 (1995) 586-591
13. + retention in man is not mediated by the mineralocorticoid receptor. J. Clin. Endocrinol. Metab. 72 5 (1991) 1060-1066
14. Sato A., Funder J.W., Okubo M., Kubota E., and Saruta T. Glucocorticoid-induced hypertension in the elderly. Relation to serum calcium and family history of essential hypertension. Am. J. Hypertens. 8 8 (1995) 823-828
15. Audran M., and Basle M.F. Ostéoporose cortisonique : de la physiopathologie au traitement. Rev. Med. Interne 12 6 (1991) 458-459 (461-4)